COVID-19 vaccine boosters may provide better protection for immunocompromised

COVID-19 vaccine boosters may provide better protection for immunocompromised

Johns Hopkins Medicine researchers have shown that three doses of vaccine against SARS-CoV-2 — the virus that causes COVID-19 — increase antibody levels more than the standard two-dose regimen for people who have received solid organ transplants. The researchers say this finding suggests booster doses should be investigated for those who are immunocompromised. Read more from Johns Hopkins Medicine here.

SEE ALL NEWS
Recent Posts
Podcast: Colorectal Cancer Why age matters when it comes to cancer Liquid Biopsy Predicts Response in Patients with Advanced Lung Cancer Experimental Drug Combination Shows Promise Against Hard-to-Treat Tumors What are the risk factors for Pancreatic Cancer? New Lung Tumor Scoring System Prostate Cancer: Advancements in Screenings 5 Healthy Habits That Help You During Lung Cancer Treatment Six Mammogram Myths